Learning Objectives:

Understand Cerebral Small Vessel Disease risk factors and their impact on pathophysiology
Recognize Cerebral Small Vessel Disease neuroimaging and its relevance for patient outcomes
Evaluate drug and lifestyle approaches for Cerebral Small Vessel Disease management.

Scientific Program:

Chair Introductions, Bo Norrving
Epidemiology, risk factors & pathophysiology, Christopher Chen
Neuroimaging and clinical implications, Simon FrandlerHöfler
Pharmacological and lifestyle interventions, Joanna Wardlaw
Q&A Discussion, moderated by Anna Bersano
Closing Remarks, World Stroke Academy

Date and Time: November 16th, 3pm (CET)